Meeting Cell Therapy Market Demand
Source: Invetech
The commercial success of a cell-based therapeutic depends on a scalable, automated manufacturing process. But how can companies ensure their manufacturing processes are up to meeting the needs and market demand of the rapidly evolving cell therapy field? Our annual breakfast briefing at the Phacilitate Leaders World conference 2020 in Miami tackled this and other current topics.
Panelists Ken Kotz from bluebird bio, Isaac Erickson from DiscGenics, Greg Bonfiglio from Proteus, LLC and Invetech's David Hodl share their vision for commercial manufacturing of cell therapies.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.
Subscribe to Cell & Gene
X
Subscribe to Cell & Gene
Invetech
This website uses cookies to ensure you get the best experience on our website. Learn more